Table 2.
Unadjusted prevalence and age-adjusted and multivariate-adjusted odds ratios for diabetes and pre-diabetes by HCV status (N=15,125 for anti-HCV analysis and 15,036 for HCV RNA analysis.)
| Diabetes status | Unadjusted prevalence (%) | Age-adjusted
|
Multivariate-adjusted*
|
||||
|---|---|---|---|---|---|---|---|
| HCV status | OR† | 95% CI | p-value | OR | 95% CI | p-value | |
| Anti-HCV | |||||||
| Diabetes | 0.72 | 0.99 | |||||
| Anti-HCV− | 10.5 | 1.0 | 1.0 | ||||
| Anti-HCV+ | 10.2 | 1.10 | 0.64 – 1.88 | 1.00 | 0.59 – 1.70 | ||
| Pre-diabetes | 0.52 | 0.79 | |||||
| Anti-HCV− | 32.7 | 1.0 | 1.0 | ||||
| Anti-HCV+ | 36.4 | 1.12 | 0.79 – 1.61 | 1.06 | 0.68 – 1.65 | ||
| HCV RNA | |||||||
| Diabetes | 0.44 | 0.84 | |||||
| HCV RNA− | 10.5 | 1.0 | 1.0 | ||||
| HCV RNA+ | 12.0 | 1.30 | 0.67 – 2.52 | 1.06 | 0.59 – 1.90 | ||
| Pre-diabetes | 0.22 | 0.53 | |||||
| HCV RNA− | 32.7 | 1.0 | 1.0 | ||||
| HCV RNA+ | 39.6 | 1.27 | 0.86 – 1.87 | 1.17 | 0.72 – 1.89 | ||
HCV, hepatitis C virus; anti-HCV, HCV antibody; OR, odds ratio; CI, confidence interval.
*
Adjusted for age, sex, race-ethnicity, education, BMI, elevated C-reactive protein, smoking, alcohol use, and blood transfusion before 1992. N=13,630 for anti-HCV analysis and N=13,554 for HCV RNA analysis.
†
From logistic regression analysis.